Utah Medical Products (UTMD) Interest Expenses (2010 - 2021)

Utah Medical Products' Interest Expenses history runs 9 years deep, the most recent figure standing at $464000.0 for Q2 2021.

• On a quarterly basis, Interest Expenses fell 13.75% year-over-year to $464000.0 in Q2 2021; TTM through Jun 2021 was $464000.0, a 13.75% decrease from a year earlier, with the FY2025 full-year figure at $307000.0, up 2690.91% from the prior year.
• Interest Expenses declined to $464000.0 in Q2 2021 per UTMD's latest filing, from $481000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $614000.0 in Q1 2019 and bottomed at $132000.0 in Q1 2020.
• The 3-year median for Interest Expenses is $533000.0 (2020), against an average of $488750.0.
• Across the five-year window, Interest Expenses tumbled 78.5% in 2020 and soared 264.39% in 2021, its largest moves.
• Year by year, Interest Expenses stood at $569000.0 in 2019, then decreased by 7.21% to $528000.0 in 2020, then declined by 12.12% to $464000.0 in 2021.
• Per Business Quant, the three latest UTMD Interest Expenses figures stand at $464000.0 (Q2 2021), $481000.0 (Q1 2021), and $528000.0 (Q3 2020).